Assignee
PROPANC PTY LTD
AU·3 granted patents·4 pending applications·1 citations·filing 2016–2022
Top patents by PatentIndex Score
7 records- 0167US10350239B2Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agentPROPANC PTY LTD·Filed 2017·Granted Jul 16, 2019·1 cites·15 claims
- 0267US2023137573A1Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction AgentPROPANC PTY LTD·Filed 2022·Application pending·0 cites
- 0353US2019388463A1Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction AgentPROPANC PTY LTD·Filed 2019·Application pending·0 cites
- 0451US2023089740A1Cancer treatmentPROPANC PTY LTD·Filed 2022·Application pending·0 cites
- 0549US12419938B2Proenzyme compositionPROPANC PTY LTD·Filed 2016·Granted Sep 23, 2025·0 cites·4 claims
- 0642US11376313B2Cancer treatmentPROPANC PTY LTD·Filed 2017·Granted Jul 5, 2022·0 cites·12 claims
- 0734US2019134166A1Composition of proenzymes for cancer treatmentPROPANC PTY LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROPANC PTY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →